Abstract
Background
Although carcinomatosis is not a contraindication to stenting in selected patients with malignant gastric outlet obstruction (GOO), associate factors for clinical success rate of self-expandable metallic stent (SEMS) placement in GOO patients with carcinomatosis have not been fully characterized.
Methods
We analyzed a total 228 patients who were scheduled for SEMS placement for malignant GOO in tertiary-care academic medical center. All patients were treated with an uncovered or covered SEMS by using the over-the-wire placement procedure. We retrospectively evaluated clinical outcomes of SEMS placement.
Results
Technical success was achieved in all patients. Patients were categorized into two groups according to the presence of carcinomatosis. Clinical success rates of patients without carcinomatosis group and with carcinomatosis group were 93.9 % (92 of 98) and 80.8 % (105 of 130), respectively (P = 0.004). In subgroup analysis of patients with carcinomatosis, the clinical success rate was lower in patients with ascites (64.8 %) than in those without ascites (92.1 %, P < 0.001). Multivariate logistic regression model revealed that carcinomatosis without ascites did not decrease clinical success rate compared with absence of carcinomatosis; meanwhile, carcinomatosis with ascites showed lower clinical success rates compared with absence of carcinomatosis (adjusted odds ratio 0.163, 95 % confidence interval 0.058–0.461). In addition, poor performance status [Eastern Cooperative Oncology Group (ECOG) status ≥3, adjusted odds ratio 0.178, 95 % confidence interval 0.078–0.409] was also an independent poor predictive factor for clinical success of SEMS placement.
Conclusions
In palliation for malignant GOO, the status of carcinomatosis with ascites and poor performance status (ECOG status ≥3) are significant predictive factors for poor clinical success of SEMS placement.
Similar content being viewed by others
References
Jung GS, Song HY, Kang SG, Huh JD, Park SJ, Koo JY, Cho YD (2000) Malignant gastroduodenal obstructions: treatment by means of a covered expandable metallic stent—initial experience. Radiology 216:758–763
Bessoud B, de Baere T, Denys A, Kuoch V, Ducreux M, Precetti S, Roche A, Menu Y (2005) Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents. J Vasc Interv Radiol 16:247–253
Maetani I, Tada T, Ukita T, Inoue H, Sakai Y, Nagao J (2004) Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 36:73–78
Maetani I, Akatsuka S, Ikeda M, Tada T, Ukita T, Nakamura Y, Nagao J, Sakai Y (2005) Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol 40:932–937
Johnsson E, Thune A, Liedman B (2004) Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg 28:812–817
Baron TH, Harewood GC (2003) Enteral self-expandable stents. Gastrointest Endosc 58:421–433
Sabharwal T, Irani FG, Adam A, Cardiovascular and Interventional Radiological Society of Europe (2007) Quality assurance guidelines for placement of gastroduodenal stents. Cardiovasc Intervent Radiol 30:1–5
Katsanos K, Sabharwal T, Adam A (2010) Stenting of the upper gastrointestinal tract: current status. Cardiovasc Intervent Radiol 33:690–705
Boskoski I, Tringali A, Familiari P, Mutignani M, Costamagna G (2010) Self-expandable metallic stents for malignant gastric outlet obstruction. Adv Ther 27:691–703
Mendelsohn RB, Gerdes H, Markowitz AJ, DiMaio CJ, Schattner MA (2011) Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc 73:1135–1140
Adler DG, Baron TH (2002) Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 97:72–78
Sasaki T, Isayama H, Nakai Y, Togawa O, Kogure H, Kawakubo K, Mizuno S, Yashima Y, Ito Y, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Omata M, Koike K (2012) Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self-expandable metallic stents for palliation. Dig Endosc 24:226–230
Kim HIHT, Kwon SJ (2010) Prognostic factors in gastric cancer patients with peritoneal carcinomatosis. J Gastric Cancer 10(3):126–132
Chen CY, Lu CL, Chang FY, Huang YS, Lee FY, Lu RH, Lih-Jiun K, Lee SD (2000) The impact of chronic hepatitis B viral infection on gastrointestinal motility. Eur J Gastroenterol Hepatol 12:995–1000
Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7:25–29
Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385–388
Neufer PD, Young AJ, Sawka MN (1989) Gastric emptying during walking and running: effects of varied exercise intensity. Eur J Appl Physiol Occup Physiol 58:440–445
Koffler KH, Menkes A, Redmond RA, Whitehead WE, Pratley RE, Hurley BF (1992) Strength training accelerates gastrointestinal transit in middle-aged and older men. Med Sci Sports Exerc 24:415–419
Oettle GJ (1991) Effect of moderate exercise on bowel habit. Gut 32:941–944
Liu F, Kondo T, Toda Y (1993) Brief physical inactivity prolongs colonic transit time in elderly active men. Int J Sports Med 14:465–467
Sangisetty SL, Miner TJ (2012) Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 4:87–95
Cavazzoni E, Bugiantella W, Graziosi L, Franceschini MS, Donini A (2013) Malignant ascites: pathophysiology and treatment. Int J Clin Oncol 18:1–9
Akiho H, Ihara E, Motomura Y, Nakamura K (2011) Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol 2:72–81
Khan WI, Collins SM (2006) Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol 143:389–397
Disclosures
Han Ho Jeon, Chan Hyuk Park, Jun Chul Park, Choong Nam Shim, Sunyong Kim, Hyun Jik Lee, Hyuk Lee, Sung Kwan Shin, Sang Kil Lee, and Yong Chan Lee have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Han Ho Jeon, Chan Hyuk Park contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jeon, H.H., Park, C.H., Park, J.C. et al. Carcinomatosis matters: clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction. Surg Endosc 28, 988–995 (2014). https://doi.org/10.1007/s00464-013-3268-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-013-3268-x